Applied Visual Sciences, an image analysis software technology company, has developed intelligent, cutting-edge imaging analytics and informatics technologies for extracting, analyzing, and detecting objects-of-interest within any still or video digital image format. The company has originated a pioneering technology platform for the automated analysis of digital imagery to extract information that can lead to the detection and identification of health-threatening diseases and explosive materials that threaten human safety and the security of critical infrastructure.
Extraction of intelligence from digital images is continually being limited by the shortcomings of human vision. No amount of training can overcome or compensate for the limitations of the human eye. Technology remains the only solution to the complex problems of image analysis. APVS’ patented machine recognition algorithms overcome the restrictions of human vision by seeing things that human eyes can’t. The company accelerates the speed of decision-making by presenting original images in ways that show otherwise indiscernible information.
APVS’ technologies save lives through automated target recognition. Unfortunate recent events have shown the inability of sophisticated scanning equipment – machines like baggage and people scanners – to prevent destruction of critical infrastructure and loss of human life. Most modern-day scanners generate high-quality images but leave image interpretation up to a human screener. Unfortunately, the complexity of identifying a shapeless and concealed explosive in a highly cluttered image is beyond the physical capabilities of human vision. APVS’ PinPoint device automates target recognition – thereby saving lives and protecting critical infrastructure.
APVS also saves lives through diagnosing tuberculosis, which is the leading killer among infectious diseases and accounts for around 1.8 million deaths every year. Fast, accurate diagnostic testing must be the first step in any defense against the spread of this disease. The company’s Signature Mapping TBDx targets laboratory shortcomings – automating the smear microscopy process, which includes the automated diagnosis of mycobacterium tuberculosis at high sensitivity and specificity levels. TBDx is capable of processing 200 stained sputum slides per microscope without human intervention.
Currently holding six patents, APVS has several applications under review. The company’s two wholly owned subsidiaries, Guardian Technologies International, Inc. and Signature Mapping Medical Sciences, Inc., have developed cutting-edge image analysis applications utilizing this intellectual property for specific market segments. Guardian Technologies International specializes in the development of automated target recognition software solutions for the homeland security and military marketplaces. Signature Mapping Medical Sciences is focused on developing automated medical diagnostic and decision support software solutions for radiology and laboratory/pathology applications.
For more information, visit the Applied Visual Sciences Web site at www.appliedvs.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment